MICHAEL LAWLER: Open Payments
NPI 1023083508 · HARRISBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$130 in 7 payments from 4 companies in 2025. Trend: 2023 $323 · 2024 $577 · 2025 $130
Food & beverage: $130
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| Supernus Pharmaceuticals, Inc. | 2 | $38 |
| ABBVIE INC. | 1 | $25 |
| Alkermes, Inc. | 1 | $14 |
Products named: CAPLYTA, Qelbree, VRAYLAR, LYBALVI.
Industry payments across PA — which companies pay providers there.
